EdenShield, a Tel Aviv, Israel-based developer of nontoxic technology for insect control, raised just over $1m in funding.
The round was led by OurCrowd.
The company, now in commercial stage, will use the funds to expand operations, establish a distribution network, and reinforce its team.
Led by Yaniv Kitron, CEO, EdenShield extracts medicinal plants endemic to Israel’s semi-desert to provide NET, which is applied to greenhouse screens, and DIRECT, which is applied directly to greenhouses flowers and medical cannabis.
It is a portfolio company of The Trendlines Group’s Trendlines Agtech,
FinSMEs
11/01/2015